Pyxis Oncology, Inc.PYXSNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank83
3Y CAGR-8.5%
5Y CAGR+50.3%
Year-over-Year Change
Research and development spending
3Y CAGR
-8.5%/yr
Annual compound
5Y CAGR
+50.3%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
7.7x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $66.01M | +12.4% |
| 2024 | $58.75M | +18.5% |
| 2023 | $49.59M | -42.4% |
| 2022 | $86.13M | +68.7% |
| 2021 | $51.05M | +493.4% |
| 2020 | $8.60M | +602.9% |
| 2019 | $1.22M | - |